These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29312888)

  • 21. Impact of dose size in single fraction spatially fractionated (grid) radiotherapy for melanoma.
    Zhang H; Zhong H; Barth RF; Cao M; Das IJ
    Med Phys; 2014 Feb; 41(2):021727. PubMed ID: 24506618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation pneumonitis after hypofractionated radiotherapy: evaluation of the LQ(L) model and different dose parameters.
    Borst GR; Ishikawa M; Nijkamp J; Hauptmann M; Shirato H; Bengua G; Onimaru R; de Josien Bois A; Lebesque JV; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1596-603. PubMed ID: 20231066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The linear-quadratic transformation of dose-volume histograms in fractionated radiotherapy.
    Wheldon TE; Deehan C; Wheldon EG; Barrett A
    Radiother Oncol; 1998 Mar; 46(3):285-95. PubMed ID: 9572622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A track-event theory of cell survival.
    Besserer J; Schneider U
    Z Med Phys; 2015 Jun; 25(2):168-75. PubMed ID: 25432332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Equivalence of the linear-quadratic and two-lesion kinetic models.
    Guerrero M; Stewart RD; Wang JZ; Li XA
    Phys Med Biol; 2002 Sep; 47(17):3197-209. PubMed ID: 12361218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.
    van Leeuwen CM; Oei AL; Crezee J; Bel A; Franken NAP; Stalpers LJA; Kok HP
    Radiat Oncol; 2018 May; 13(1):96. PubMed ID: 29769103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Choice of model and uncertainties of the gamma-ray and neutron dosimetry in relation to the chromosome aberrations data in Hiroshima and Nagasaki.
    Rühm W; Walsh L; Chomentowski M
    Radiat Environ Biophys; 2003 Jul; 42(2):119-28. PubMed ID: 12844221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biophysical analysis of the dose-dependent overdispersion and the restricted linear energy transfer dependence expressed in dicentric chromosome data from alpha-irradiated human lymphocytes.
    Greinert R; Harder D
    Radiat Environ Biophys; 1997 Jun; 36(2):89-95. PubMed ID: 9271796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy.
    Wang JZ; Huang Z; Lo SS; Yuh WT; Mayr NA
    Sci Transl Med; 2010 Jul; 2(39):39ra48. PubMed ID: 20610850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of hypersensitivity to fractionated low-dose radiation exposure.
    Smith LG; Miller RC; Richards M; Brenner DJ; Hall EJ
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):187-91. PubMed ID: 10477023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Unified Dose Response Relationship to Predict High Dose Fractionation Response in the Lung Cancer Stereotactic Body Radiation Therapy.
    Kehwar TS; Chopra KL; Rai DV
    J Med Phys; 2017; 42(4):222-233. PubMed ID: 29296036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The response of mouse skin to irradiation with neutrons from the 62 MV cyclotron at Clatterbridge, U.K.
    Joiner MC; Field SB
    Radiother Oncol; 1988 Jun; 12(2):153-66. PubMed ID: 3406459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammalian cell killing by ultrasoft X rays and high-energy radiation: an extension of the MK model.
    Hawkins RB
    Radiat Res; 2006 Aug; 166(2):431-42. PubMed ID: 16881744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The linear-quadratic model and fractionated stereotactic radiotherapy.
    Liu L; Bassano DA; Prasad SC; Hahn SS; Chung CT
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):827-32. PubMed ID: 14529790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Research of Biological Dose Conversion Platform Based on a Modified Linear Quadratic Model.
    Dai LY; Huang RH; Zhou Y; le Gu H; Wang YB; Yang CCJ; Xu X; Ye M; Bai YR; Liu YL; Li XB; Ma XM
    Dose Response; 2019; 17(1):1559325819828623. PubMed ID: 30944552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A LQ-based kinetic model formulation for exploring dynamics of treatment response of tumours in patients.
    Scheidegger S; Lutters G; Bodis S
    Z Med Phys; 2011 Sep; 21(3):164-73. PubMed ID: 21237624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning.
    Guerrero M; Li XA
    Phys Med Biol; 2003 Oct; 48(20):3307-26. PubMed ID: 14620060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor Control Probability Analysis for Single-Fraction Carbon-Ion Radiation Therapy of Early-Stage Non-small Cell Lung Cancer.
    Paz AE; Yamamoto N; Sakama M; Matsufuji N; Kanai T
    Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1551-1559. PubMed ID: 30076985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocyte radiosensitivity: An extension to the linear-quadratic model?
    Pham TN; Coupey J; Thariat J; Valable S
    Radiother Oncol; 2024 Jun; 198():110406. PubMed ID: 38925262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.